Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Focal Onset Seizure”

207 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 207 results

Large-scale testing (Phase 3)Study completedNCT00848549
What this trial is testing

Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures

Who this might be right for
Epilepsy
Eisai Inc. 295
Early research (Phase 1)Study completedNCT01355068
What this trial is testing

Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia

Who this might be right for
Healthy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 26
Large-scale testing (Phase 3)Study completedNCT01463306
What this trial is testing

A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

Who this might be right for
Epilepsy, Partial SeizuresEpilepsy, Primary Generalized Tonic-Clonic Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 605
Large-scale testing (Phase 3)Study completedNCT00141388
What this trial is testing

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures

Who this might be right for
Seizure Disorder, Partial
Pfizer 455
Large-scale testing (Phase 3)Study completedNCT00957372
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 253
Not applicableUnknownNCT05571371
What this trial is testing

Inflammatory Biomarkers in Psychogenic Non-epileptic Seizure

Who this might be right for
Localization-Related (Focal) (Partial) Idiopathic Epilepsy and Epileptic Syndromes With Seizures of Localized OnsetTRAIL: Tumor Necrosis Factor Related Apoptosis Inducing Ligand MCP-2MCP-2: Monocyte Chemo-attractant Protein-2
Esraa Mostafa Ahmed Abdel Aal 90
Testing effectiveness (Phase 2)Study completedNCT06377930
What this trial is testing

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

Who this might be right for
Focal Onset Seizures
Rapport Therapeutics Inc. 30
Not applicableLooking for participantsNCT06716801
What this trial is testing

Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain

Who this might be right for
Focal Epilepsy With and Without Secondary Generalization
Aziende Chimiche Riunite Angelini Francesco S.p.A 300
Large-scale testing (Phase 3)Study completedNCT00136019
What this trial is testing

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Who this might be right for
Epilepsy
UCB Pharma 400
Large-scale testing (Phase 3)Study completedNCT00603473
What this trial is testing

A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

Who this might be right for
Epilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 92
Not applicableStudy completedNCT01073579
What this trial is testing

Sabril Patient Registry

Who this might be right for
Infantile SpasmsRefractory Complex Partial Seizures in Adults
Lundbeck LLC 9,423
Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Post-approval studies (Phase 4)Study completedNCT05533814
What this trial is testing

Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures

Who this might be right for
Epilepsy
Eisai Korea Inc. 125
Large-scale testing (Phase 3)Study completedNCT00151879
What this trial is testing

Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

Who this might be right for
Epilepsies, Partial
UCB Pharma 160
Testing effectiveness (Phase 2)Ended earlyNCT04529954
What this trial is testing

Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion

Who this might be right for
Focal Epilepsy
Cerebral Therapeutics LLC 20
Testing effectiveness (Phase 2)Study completedNCT02170077
What this trial is testing

A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093

Who this might be right for
Epilepsy
Bial - Portela C S.A. 144
Testing effectiveness (Phase 2)Looking for participantsNCT07219407
What this trial is testing

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

Who this might be right for
Focal EpilepsyEpilepsyRefractory Focal Epilepsy+3 more
Rapport Therapeutics Inc. 30
Post-approval studies (Phase 4)Study completedNCT00275925
What this trial is testing

Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures

Who this might be right for
Epilepsy, Partial Seizures
Novartis 80
Testing effectiveness (Phase 2)Study completedNCT00236691
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 188
Post-approval studies (Phase 4)Ended earlyNCT01546688
What this trial is testing

Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Limited 41
Load More Results